Hematopoietic stem cell transplantation (HSCT) is a curative treatment for a range of haematological malignancies and disorders by replacing diseased or damaged bone marrow with healthy stem cells.

An existing transplant drug has shown promise in slowing the progression of type 1 diabetes in newly diagnosed young people, potentially paving the way for the first therapy that modifies the disease ...

Cytokine release syndrome occurred in 33 and 24% of participants in the ATG 2.5- and 0.5mg/kg groups, respectively, and in no participants in the placebo group. HealthDay News — Antithymocyte globulin ...

ATG 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes. (HealthDay News) — Antithymocyte globulin (ATG) 2.5 and 0.5 mg/kg reduces loss of β-cell ...